Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

TBC (halobetasol propionate and tazarotene)

Indications: Psoriasis, moderate to severe plaque

Call For Patient Input: January 7, 2019

Patient Input Closed: February 26, 2019

Xultophy (insulin degludec + liraglutide)

Indications: Diabetes mellitus, Type 2

Call For Patient Input: January 2, 2019

Patient Input Closed: February 21, 2019

TBC (patisiran )

Indications: Polyneuropathy in hereditary transthyretin-mediated amyloidosis

Call For Patient Input: December 20, 2018

Patient Input Closed: February 15, 2019